Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs ISTREET NETWORK - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. ISTREET NETWORK GENNEX LAB./
ISTREET NETWORK
 
P/E (TTM) x 35.0 -37.6 - View Chart
P/BV x 4.5 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GENNEX LAB.   ISTREET NETWORK
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
ISTREET NETWORK
Mar-23
GENNEX LAB./
ISTREET NETWORK
5-Yr Chart
Click to enlarge
High Rs94 225.8%   
Low Rs52 304.4%   
Sales per share (Unadj.) Rs3.40-  
Earnings per share (Unadj.) Rs0.3-0.1 -246.2%  
Cash flow per share (Unadj.) Rs0.3-0.1 -292.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs4.5-1.1 -414.9%  
Shares outstanding (eoy) m176.6421.30 829.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.10-  
Avg P/E ratio x25.0-24.8 -100.5%  
P/CF ratio (eoy) x21.0-24.8 -84.7%  
Price / Book Value ratio x1.5-2.6 -59.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,22960 2,056.2%   
No. of employees `000NANA-   
Total wages/salary Rs m790 26,240.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5930-  
Other income Rs m400 43,922.2%   
Total revenues Rs m6330 703,366.7%   
Gross profit Rs m47-3 -1,877.2%  
Depreciation Rs m90-   
Interest Rs m140-   
Profit before tax Rs m64-2 -2,644.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m150-   
Profit after tax Rs m49-2 -2,041.9%  
Gross profit margin %7.90- 
Effective tax rate %22.80-   
Net profit margin %8.30- 
BALANCE SHEET DATA
Current assets Rs m4872 20,984.1%   
Current liabilities Rs m2952 19,675.3%   
Net working cap to sales %32.30- 
Current ratio x1.61.5 106.7%  
Inventory Days Days40- 
Debtors Days Days57,912,5890- 
Net fixed assets Rs m8351 100,597.6%   
Share capital Rs m18085 211.5%   
"Free" reserves Rs m623-109 -574.2%   
Net worth Rs m804-23 -3,441.1%   
Long term debt Rs m16318 904.9%   
Total assets Rs m1,3223 41,961.6%  
Interest coverage x5.70-  
Debt to equity ratio x0.2-0.8 -26.3%  
Sales to assets ratio x0.40-   
Return on assets %4.7-76.4 -6.2%  
Return on equity %6.110.3 59.4%  
Return on capital %8.045.0 17.8%  
Exports to sales %42.10-  
Imports to sales %13.60-  
Exports (fob) Rs m250NA-   
Imports (cif) Rs m81NA-   
Fx inflow Rs m2500-   
Fx outflow Rs m860-   
Net fx Rs m1640-   
CASH FLOW
From Operations Rs m237-3 -8,192.4%  
From Investments Rs m-383-1 66,084.5%  
From Financial Activity Rs m210-2 -10,516.5%  
Net Cashflow Rs m64-5 -1,168.7%  

Share Holding

Indian Promoters % 23.6 46.2 51.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 53.8 142.0%  
Shareholders   69,723 10,354 673.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs PRINCIPAL PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs PRINCIPAL PHARMA Share Price Performance

Period GENNEX LABORATORIES PRINCIPAL PHARMA S&P BSE HEALTHCARE
1-Day 1.35% -1.74% 1.18%
1-Month -13.90% -6.61% -0.75%
1-Year 189.91% 18.95% 61.82%
3-Year CAGR 62.78% 20.55% 18.16%
5-Year CAGR 40.09% 14.67% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the PRINCIPAL PHARMA share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of PRINCIPAL PHARMA the stake stands at 46.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of PRINCIPAL PHARMA.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

PRINCIPAL PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of PRINCIPAL PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.